Study title: A double-blind, placebo-controlled trial to evaluate the efficacy and safety of topically applied 0.1% isotretinoin cream for the treatment of acne vulgaris.
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Skin and Connective Tissue Diseases [C17] | |||||
Brands: Please see report, Please see report, Please see report, Please see report, Please see report, Please see report | |||||
MAH holders: Please see report, Please see report | |||||
Assessment: | |||||
Active substance: ISOTRETINOIN | |||||
ATC code: D10BA01 | |||||
Document link: | |||||
Document date: | |||||
Study number: 1003270 | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | Y | - |